Changying Guo
Xinjiang Key Laboratory Of Biological Resources And Genetic Engineering
Ueruemqi, China
Ueruemqi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
PMN-MDSCs-derived exosomal S100A9 drives breast cancer progression by enhancing cancer stemness and CXCL5-mediated metastatic potential.
Journal: Cell death discovery
Published: December 07, 2025
lncRNA EGFR-AS1 promotes DNA damage repair by enhancing PARP1-mediated PARylation.
Journal: The Journal of cell biology
Published: January 11, 2025
Antigen cross-presentation in dendric cells: From bench to bedside.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 30, 2023
Heat-shock protein 90α protects NME1 against degradation and suppresses metastasis of breast cancer.
Heat-shock protein 90α protects NME1 against degradation and suppresses metastasis of breast cancer.
Journal: British journal of cancer
Published: November 23, 2022
An improved cell line-derived xenograft humanized mouse model for evaluation of PD-1/PD-L1 blocker BMS202-induced immune responses in colorectal cancer.
Journal: Acta biochimica et biophysica Sinica
Published: October 21, 2022
Oncoprotein SET dynamically regulates cellular stress response through nucleocytoplasmic transport in breast cancer.
Journal: Cell biology and toxicology
Published: July 15, 2022
Dynamics of estrogen-induced ROS and DNA strand break generation in estrogen receptor α-positive breast cancer.
Journal: Biochemical and biophysical research communications
Published: February 21, 2022
SET/PP2A signaling regulates macrophage positioning in hypoxic tumor regions by amplifying chemotactic responses.
Journal: Experimental & molecular medicine
Published: February 10, 2022
Crosstalk between macrophages and natural killer cells in the tumor microenvironment.
Journal: International immunopharmacology
Published: September 16, 2021
Phycocyanin-functionalized black phosphorus quantum dots enhance PDT/PTT therapy by inducing ROS and irreparable DNA damage.
Journal: Biomaterials science
Published: June 29, 2021
The multiple regulation of metastasis suppressor NM23-H1 in cancer.
Journal: Life sciences
Published: September 30, 2020
Correction: miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via downregulating histone H4K20 trimethylation through directly targeting SUV420H2.
Journal: Cell death & disease
Published: November 14, 2019
Last Updated: 09/26/2026